"Beauty is a light in the heart": The transformative potential of optogenetics for clinical applications in cardiovascular medicine

Trends in Cardiovascular Medicine

Volumn 25, Issue 2, 2015, Pages 73-81

  Boyle, Patrick M ^a,b   Karathanos, Thomas V ^a,b   Trayanova, Natalia A ^a,b  

^a Johns Hopkins University   (United States)

^b Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CONCEPTUAL FRAMEWORK; FEASIBILITY STUDY; HUMAN; ILLUMINATION; IN VITRO STUDY; MATHEMATICAL COMPUTING; MONOLAYER CULTURE; NONHUMAN; OPTOGENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIMULATION; TECHNOLOGY; TRANSGENIC ANIMAL; CARDIOVASCULAR DISEASES; COMPUTER SIMULATION; PROCEDURES;

CARDIOVASCULAR DISEASES; COMPUTER SIMULATION; HUMANS; OPTOGENETICS;

EID: 84923104375     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2014.10.004     Document Type: Review

References (46)

1. Nagel G., Szellas T., Huhn W., Kateriya S., Adeishvili N., Berthold P., et al. Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc Natl Acad Sci U S A. 2003, 100:13940-13945.
2. Boyden E.S., Zhang F., Bamberg E., Nagel G., Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 2005, 8:1263-1268.
3. Zhang F., Wang L.P., Boyden E.S., Deisseroth K. Channelrhodopsin-2 and optical control of excitable cells. Nat Methods 2006, 3:785-792.
4. Knopfel T., Lin M.Z., Levskaya A., Tian L., Lin J.Y., Boyden E.S. Toward the second generation of optogenetic tools. J Neurosci 2010, 30:14998-15004.
5. Chow B.Y., Boyden E.S. Optogenetics and translational medicine. Sci Transl Med 2013, 5:177ps5.
6. Entcheva E. Cardiac optogenetics. Am J Physiol Heart Circ Physiol 2013, 304:H1179-H1191.
7. Boyle P.M., Entcheva E., Trayanova N.A. See the light: can optogenetics restore healthy heartbeats? And, if it can, is it really worth the effort?. Expert Rev Cardiovasc Ther 2014, 12:17-20.
8. Jung J., Hahn S.J., Heisel A., Buob A., Schubert B.D., Siaplaouras S. Defibrillation efficacy and pain perception of two biphasic waveforms for internal cardioversion of atrial fibrillation. J Cardiovasc Electrophysiol 2003, 14:837-840.
9. Merrill D.R., Bikson M., Jefferys J.G.R. Electrical stimulation of excitable tissue: design of efficacious and safe protocols. J Neurosci Methods 2005, 141:171-198.
10. Boyle P.M., Williams J.C., Ambrosi C.M., Entcheva E., Trayanova N.A. A comprehensive multiscale framework for simulating optogenetics in the heart. Nat Commun 2013, 4:2370.
11. Bruegmann T., Malan D., Hesse M., Beiert T., Fuegemann C.J., Fleischmann B.K., et al. Optogenetic control of heart muscle in vitro and in vivo. Nat Methods 2010, 7:897-900.
12. Arrenberg A.B., Stainier D.Y., Baier H., Huisken J. Optogenetic control of cardiac function. Science 2010, 330:971-974.
13. Abilez O.J., Wong J., Prakash R., Deisseroth K., Zarins C.K., Kuhl E. Multiscale computational models for optogenetic control of cardiac function. Biophys J 2011, 101:1326-1334.
14. Jia Z., Valiunas V., Lu Z., Bien H., Liu H., Wang H.Z., et al. Stimulating cardiac muscle by light: cardiac optogenetics by cell delivery. Circ Arrhythm Electrophysiol 2011, 4:753-760.
15. Nussinovitch U., Shinnawi R., Gepstein L. Modulation of cardiac tissue electrophysiological properties with light-sensitive proteins. Cardiovasc Res 2014, 102:176-187.
16. Beiert T., Bruegmann T., Sasse P. Optogenetic activation of Gq signalling modulates pacemaker activity of cardiomyocytes. Cardiovasc Res 2014, 102:507-516.
17. Lin J.Y., Knutsen P.M., Muller A., Kleinfeld D., Tsien R.Y. ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nat Neurosci 2013, 16:1499-1508.
18. Klapoetke N.C., Murata Y., Kim S.S., Pulver S.R., Birdsey-Benson A., Cho Y.K., et al. Independent optical excitation of distinct neural populations. Nat Methods 2014, 11:338-346.
19. Trayanova N.A., Boyle P.M. Advances in modeling ventricular arrhythmias: from mechanisms to the clinic. Wiley Interdiscip Rev Syst Biol Med 2014, 6:209-224.
20. Bamann C., Kirsch T., Nagel G., Bamberg E. Spectral characteristics of the photocycle of channelrhodopsin-2 and its implication for channel function. J Mol Biol 2008, 375:686-694.
21. Nikolic K., Grossman N., Grubb M.S., Burrone J., Toumazou C., Degenaar P. Photocycles of channelrhodopsin-2. Photochem Photobiol 2009, 85:400-411.
22. Williams J.C., Xu J., Lu Z., Klimas A., Chen X., Ambrosi C.M., et al. Computational optogenetics: empirically-derived voltage- and light-sensitive channelrhodopsin-2 model. PLoS Comput Biol 2013, 9:e1003220-e.
23. Entcheva E., Williams J.C. Channelrhodopsin2 current during the action potential: "optical AP clamp" and approximation. Sci Rep 2014, 4:5838.
24. Prasad K-MR, Smith R.S., Xu Y., French B.A. A single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction. J Gene Med 2011, 13:333-341.
25. Prasad K.M., Xu Y., Yang Z., Acton S.T., French B.A. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther 2011, 18:43-52.
26. Rosen A.B., Kelly D.J., Schuldt A.J.T., Lu J., Potapova I.A., Doronin S.V., et al. Finding fluorescent needles in the cardiac haystack: tracking human mesenchymal stem cells labeled with quantum dots for quantitative in vivo three-dimensional fluorescence analysis. Stem Cells 2007, 25:2128-2138.
27. Bishop M.J., Rodriguez B., Eason J., Whiteley J.P., Trayanova N., Gavaghan D.J. Synthesis of voltage-sensitive optical signals: application to panoramic optical mapping. Biophys J 2006, 90:2938-2945.
28. Baxter W.T., Mironov S.F., Zaitsev A.V., Jalife J., Pertsov A.M. Visualizing excitation waves inside cardiac muscle using transillumination. Biophys J 2001, 80:516-530.
29. Bishop M.J., Plank G. Simulating photon scattering effects in structurally detailed ventricular models using a Monte Carlo approach. Front Physiol 2014, 5.
30. Ambrosi C.M., Klimas A., Yu J., Entcheva E. Cardiac applications of optogenetics. Prog Biophys Mol Biol 2014, 115:294-304.
31. Tilemann L., Ishikawa K., Weber T., Hajjar R.J. Gene therapy for heart failure. Circ Res 2012, 110:777-793.
32. Kikuchi K., McDonald A.D., Sasano T., Donahue J.K. Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer. Circulation 2005, 111:264-270.
33. Malliaras K., Makkar R.R., Smith R.R., Cheng K., Wu E., Bonow R.O., et al. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol 2014, 63:110-122.
34. Hare J.M., Fishman J.E., Gerstenblith G., DiFede Velazquez D.L., Zambrano J.P., Suncion V.Y., et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. J Am Med Assoc 2012, 308:2369-2379.
35. Wu K.H., Mo X.M., Han Z.C., Zhou B. Stem cell engraftment and survival in the ischemic heart. Ann Thorac Surg 2011, 92:1917-1925.
36. Chong J.J., Yang X., Don C.W., Minami E., Liu Y.W., Weyers J.J., et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 2014, 510:273-277.
37. Miyashita T., Shao Y.R., Chung J., Pourzia O., Feldman D.E. Long-term channelrhodopsin-2 (ChR2) expression can induce abnormal axonal morphology and targeting in cerebral cortex. Front Neural Circuits 2013, 7:8.
38. Kim T.I., McCall J.G., Jung Y.H., Huang X., Siuda E.R., Li Y., et al. Injectable, cellular-scale optoelectronics with applications for wireless optogenetics. Science 2013, 340:211-216.
39. Kim R.H., Kim D.H., Xiao J., Kim B.H., Park S.I., Panilaitis B., et al. Waterproof AlInGaP optoelectronics on stretchable substrates with applications in biomedicine and robotics. Nat Mater 2010, 9:929-937.
40. Xu L., Gutbrod S.R., Bonifas A.P., Su Y., Sulkin M.S., Lu N., et al. 3D multifunctional integumentary membranes for spatiotemporal cardiac measurements and stimulation across the entire epicardium. Nat Commun 2014, 5:3329.
41. Venkataraman G., Mathur D., Joshi S., Strickberger A. Comparison of ICD implantation in obese and nonobese patients. Pacing Clin Electrophysiol 2014, 37:481-485.
42. Tsubota T., Ohashi Y., Tamura K., Sato A., Miyashita Y. Optogenetic manipulation of cerebellar Purkinje cell activity in vivo. PLoS One 2011, 6:e22400-e.
43. Barba-Pichardo R., Sánchez A.M., Fernández-Gómez J.M., Moriña-Vázquez P., Venegas-Gamero J., Herrera-Carranza M. Ventricular resynchronization therapy by direct His-bundle pacing using an internal cardioverter defibrillator. Europace 2013, 15:83-88.
44. Karathanos T.V., Boyle P.M., Trayanova N.A. Optogenetics-enabled dynamic modulation of action potential duration in atrial tissue: feasibility of a novel therapeutic approach. Europace 2014, 16(Suppl 4):iv62-iv68.
45. Park S.A., Lee S.R., Tung L., Yue D.T. Optical mapping of optogenetically shaped cardiac action potentials. Sci Rep 2014, 4:6125.
46. Bingen B.O., Engels M.C., Schalij M.J., Jangsangthong W., Neshati Z., Feola I., et al. Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytes. Cardiovasc Res 2014, 104:194-205.